Sign in
4

Changes in Ownership

Akari Therapeutics Plc Filed Acc 0001493152-26-045366

CEO acquired 6,430 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gaslightwala Abizer · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-29 Grant or award : show line 1 in the form +6,430 $9.72 $62,500 14,107 D
Loading xslF345X06/ownership.xml…